Provided by Tiger Trade Technology Pte. Ltd.

INVESCO BIOTECHNOLOGY & GENOME ETF

95.67
+2.302.46%
Post-market: 95.680.0102+0.01%19:30 EDT
Volume:10.42K
Turnover:991.30K
Market Cap:415.21M
PE:53.35
High:95.68
Open:93.80
Low:93.80
Close:93.37
52wk High:98.82
52wk Low:67.69
Shares:4.34M
Float Shares:4.34M
Volume Ratio:0.92
T/O Rate:0.24%
Dividend:1.55
Dividend Rate:1.62%
EPS(TTM):1.79
EPS(LYR):18.65
ROE:24.76%
ROA:0.08%
PB:1.68
PE(LYR):5.13

Loading ...

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

TIPRANKS
·
Sep 15

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Sep 14

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Reuters
·
Sep 14

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS
·
Sep 14

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS
·
Sep 14

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS
·
Sep 14

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS
·
Sep 14

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 14

Vertex Minerals Revises Timeline for Proposed Securities Issue

TIPRANKS
·
Sep 14

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

TIPRANKS
·
Sep 12

US FDA Approves Scholar Rock's Muscle Weakness Drug

Reuters
·
Sep 12

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

IntegraGen receives rival takeover bids amid court‑ordered restructuring

TIPRANKS
·
Sep 12

Political and General News Events from September 11

Reuters
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Champions Oncology Q1 Revenue Rises on Research Services Business

Reuters
·
Sep 11

Amgen’s New Repatha Plaque Trial: What Investors Should Watch

TIPRANKS
·
Sep 11